Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 35 EP applications Julie Carlisle has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11843945

INTEGRIN-LINKED KINASE INHIBITORS

IPC classification:
A61K 31/415, A01N 43/56
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13175481

Process for producing substituted methylamine compound and triazine derivative

IPC classification:
C07D 401/14, C07D 401/06, C07B 43/04, C07D 213/61
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13175480

Process for producing substituted methylamine compound and triazine derivative

IPC classification:
C07D 401/14, C07D 401/06, C07B 43/04, C07D 213/61
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP13174255

Plant disease control agent

IPC classification:
A01N 47/18, A01P 3/00, A01N 59/20, A01N 57/12, A01N 55/02, A01N 51/00, A01N 47/44, A01N 47/34, A01N 47/12, A01N 47/04, A01N 43/653, A01N 43/54, A01N 43/50, A01N 43/36, A01N 37/46, A01N 37/34, A01N 43/713
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP12749942

USE OF TEMPLATE SWITCHING FOR DNA SYNTHESIS

IPC classification:
C12Q 1/68, C12N 15/10
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12760881

AQUEOUS HORTICULTURAL MICROBICIDAL COMPOSITION SUSPENSION

IPC classification:
A01P 3/00, A01N 43/713, A01N 25/30, A01N 25/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12781697

LIQUID INSECTICIDE COMPOSITION

IPC classification:
A01P 7/04, A01N 47/40, A01N 25/30, A01N 25/02
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12815454

RUTHENIUM CARBON MONOXIDE RELEASING MOLECULES AND USES THEREOF

IPC classification:
A61K 39/40, A01N 59/04, A01N 55/02
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12836312

METHOD FOR PRODUCING ELECTRODE COVERED WITH SODIUM METAL

IPC classification:
H01M 4/1395, H01M 4/134, C23C 26/00, C23C 14/14, C23C 2/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP12838482

SILYLATED POLYBUTADIENE

IPC classification:
C08L 47/00, C08K 5/14, C08F 36/06, C08F 8/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12834802

INTACT MASS DETERMINATION OF PROTEIN CONJUGATED AGENT COMPOUNDS

IPC classification:
G01N 24/00
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12841303

NOVEL COPOLYMER

IPC classification:
G02B 5/20, C09B 67/20, C08F 297/02
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12850965

PHOTOCATALYST-SUPPORTING STRUCTURE

IPC classification:
B32B 27/00, B32B 9/00, B32B 7/12, B01J 35/02
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13782216

DR5 LIGAND DRUG CONJUGATES

IPC classification:
A61K 39/395
Applicant:
Seattle Genetics, Inc.
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182732

Auristatin drug linker conjugates

IPC classification:
A61K 47/48, A61K 38/00, C07K 5/02
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
The patent has been granted
EP14185157

Thioninium compounds and their use

IPC classification:
A61K 31/5415, A61P 25/28
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13804801

METHOD FOR PRODUCING AZIDE COMPOUND, AND METHOD FOR PRODUCING 1H-TETRAZOLE DERIVATIVE

IPC classification:
C07D 257/04, C07C 247/04
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13813323

COMPOSITION CONTAINING BIOLOGICALLY ACTIVE SUBSTANCE

IPC classification:
A61K 47/42, A61K 47/12, A61K 45/00, A61K 31/198, A61K 9/42, A23K 1/18, A23K 1/16, A61P 1/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13816684

ORGANIC-INORGANIC COMPLEX, AND FORMING COMPOSITION THEREOF

IPC classification:
C08L 101/00, C08L 83/04, C08K 5/5419, C07F 7/18, B32B 9/00
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13819250

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

IPC classification:
A61K 9/127
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13820351

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

IPC classification:
A61K 9/127
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13831167

TREATMENT OF SICKLE CELL DISEASE AND INFLAMMATORY CONDITIONS

IPC classification:
A61K 31/7048, A61K 31/7024, A61K 31/7004, A61P 7/00, A61P 3/00
Applicant:
Regents of the University of Minnesota
Applicant:
Seattle Genetics, Inc.
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13759274

FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE

IPC classification:
A61K 31/4439, A61K 31/427, C07D 417/14, C07D 417/10, C07D 413/10, A61P 35/00
Applicant:
The Institute of Cancer Research - Royal Cancer Hospital
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13833806

EXTRACTION METHOD

IPC classification:
B01D 11/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13834929

PLANT GROWTH ACCELERATOR

IPC classification:
A01P 21/00, A01N 43/653, A01N 25/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13845276

ROD-SHAPED PLANT VIRUS NANOPARTICLES AS IMAGING AGENT PLATFORMS

IPC classification:
A61K 49/06
Applicant:
Case Western Reserve University
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13849834

MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB

IPC classification:
A61K 38/06, C07D 277/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12744261

SUGAR EXTRACTS

IPC classification:
C13K 13/00, A23L 1/30, A23K 1/16, A23K 1/18, A61P 3/04, A23L 1/307, A23L 1/29, A23K 1/02
Agent:
Julie Carlisle, Mewburn Ellis LLP
Agent:
Stéphane Agasse, Cabinet Germain & Maureau
Status:
EXAMINATION REQUESTED
EP14789349

METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC)

IPC classification:
C07D 279/18
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14802705

SELECTIVE GLUCOCORTICOID RECEPTOR LIGANDS

IPC classification:
A61P 5/44, A61K 31/58, A61K 31/56, C07J 43/00, C07J 41/00
Applicant:
University of Manchester
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13171810

Alkylated heterocyclic reaction products useful as antioxidants

IPC classification:
C08K 5/18, C10M 159/12, C10M 149/14, C07C 39/16, C10M 135/34, C10M 129/20, C08K 5/47, C08K 5/3415, C08K 5/13, C07C 215/74, C07D 333/18, C07D 333/16, C07D 307/42, C07C 213/08
Applicant:
Albemarle Corporation
Agent:
Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15743124

METHODS OF TREATING AND IMAGING TUMOR MICROMETASTASES USING PHOTOACTIVATABLE IMMUNOCONJUGATES

IPC classification:
G01J 1/48, A61K 49/00, A61K 41/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15174121

PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER

IPC classification:
A61K 49/10, A61K 49/00
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15766414

QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS

IPC classification:
A61P 35/00, A61K 31/4704, C07D 215/38, C07D 215/36
Applicant:
UCL Business plc
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
Request for examination was made
EP15839387

CRYSTAL POLYMORPHISM OF INCLUSION COMPOUND AND METHOD FOR PRODUCING SAME, AND CURABLE RESIN COMPOSITION

IPC classification:
C08G 59/62, C08G 59/40, C07C 39/15, C07C 37/84, C07D 233/64
Applicant:
Nippon Sōda Company Limited (Nippon Sōda Kabushiki Kaisha)
Agent:
Julie Carlisle, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature